Get the Stockscreener App
4.7954
12.59%
-0.6846
Novabay Pharmaceuticals Inc stock is traded at $4.7954, with a volume of 754.68K.
It is down -12.59% in the last 24 hours and up +4.81% over the past month.
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$5.48
Open:
$5.27
24h Volume:
754.68K
Relative Volume:
0.56
Market Cap:
$605.63M
Revenue:
$4.75M
Net Income/Loss:
$-7.83M
P/E Ratio:
22.03
EPS:
0.2177
Net Cash Flow:
$-7.24M
1W Performance:
-67.57%
1M Performance:
+4.81%
6M Performance:
+630.74%
1Y Performance:
+574.55%
1-Day Range:
$4.64
$5.27
1-Week Range:
$4.64
$11.11
52-Week Range:
$0.46
$19.95
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Name
Novabay Pharmaceuticals Inc
Sector
Industry
Phone
510-899-8800
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
4.80 | 691.43M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.01 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.87 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.61 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.31 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-19 | Initiated | Ladenburg Thalmann | Buy |
| Jul-06-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Reiterated | Laidlaw | Buy |
| Jun-05-17 | Initiated | ROTH Capital | Buy |
| Mar-27-17 | Initiated | Laidlaw | Buy |
| Feb-06-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-07-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-14-15 | Reiterated | Maxim Group | Buy |
| Apr-30-15 | Resumed | Maxim Group | Buy |
| Mar-06-13 | Initiated | Ascendiant Capital Markets | Strong Buy |
| Jan-03-08 | Initiated | Dawson James | Speculative Buy |
View All
Novabay Pharmaceuticals Inc Stock (NBY) Latest News
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Down 14.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement By Investing.com - Investing.com Canada
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Gap DownShould You Sell? - MarketBeat
NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha
NovaBay Pharmaceuticals (NBY) Announces $100M Stock Sale Agreement with Virtu Americas - Intellectia AI
Aug PostEarnings: What is NovaBay Pharmaceuticals Incs 5 year growth outlookJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
NovaBay Pharmaceuticals stock falls after $100 million ATM offering By Investing.com - Investing.com Canada
NovaBay Pharma Establishes $100 Million ATM Equity Program - TipRanks
NovaBay Pharmaceuticals enters $100 million at-the-market sales agreement - Investing.com
NovaBay Pharmaceuticals Signs ATM Sales Agreement With Virtu Americas - TradingView — Track All Markets
NBY Stock Price, Forecast & Analysis | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - Chartmill
Performance Recap: Does NovaBay Pharmaceuticals Inc have a sustainable dividend2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn
Is NovaBay Pharmaceuticals Inc stock heavily shortedWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Jobs Data: What is NovaBay Pharmaceuticals Incs 5 year growth outlookWeekly Investment Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants By Investing.com - Investing.com Nigeria
NovaBay Pharmaceuticals announces $134 million private placement of pre-funded warrants - Investing.com Nigeria
NovaBay Pharma Secures Crypto-Focused Financing, Shifts Strategy - TipRanks
NovaBay Pharmaceuticals Signs Multiple Material Agreements - TradingView — Track All Markets
NovaBay (NYSE: NBY) sells pre-funded warrants for $134M financing - Stock Titan
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Trading Up 13.2%Time to Buy? - MarketBeat
Decliners Report: Is QDWN subject to activist investor interestPortfolio Gains Report & AI Enhanced Trading Alerts - baoquankhu1.vn
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Down 8.3%Should You Sell? - MarketBeat
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Increase in Short Interest - MarketBeat
Buybacks Report: Can NovaBay Pharmaceuticals Inc stock sustain market leadership2025 Technical Overview & Community Verified Watchlist Alerts - Bộ Nội Vụ
Hedge Fund Bets: How supply chain issues affect NovaBay Pharmaceuticals Inc. stockMarket Growth Review & Stock Timing and Entry Methods - Bộ Nội Vụ
NovaBay: 'Hold' Rating As New M&A Direction Could Evolve But With Risks (NYSE:NBY) - Seeking Alpha
Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - Sahm
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Exploded 103% on Friday - Blockonomi
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar - TechStock²
NovaBay Pharmaceuticals (NBY) Stock: Why Shares Just Doubled in One Day - CoinCentral
NovaBay stock more than doubles on thin float — what to watch for NBY when markets reopen - TechStock²
NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday - TechStock²
Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - Yahoo Finance
NovaBay Pharmaceuticals stock doubles as NBY volatility flares again — what to watch next - TechStock²
Published on: 2026-01-11 02:58:32 - ulpravda.ru
Novabay Pharmaceuticals stock hits 52-week high at 11.49 USD By Investing.com - Investing.com Nigeria
NovaBay stock more than doubles as microcap swings widen; warrants in focus ahead of CPI - TechStock²
How NovaBay Pharmaceuticals Inc. (B9P0) stock trades after earnings2025 Pullback Review & AI Optimized Trading Strategy Guides - Улправда
Crypto: NovaBay Pharmaceuticals (NBY) Soars 102.54%Is This The Start of a New Era? - InteractiveCrypto
Crypto: NBY's Wild Ride: Why NovaBay Pharmaceuticals Is the Market's Hottest Stock - InteractiveCrypto
Can NovaBay Pharmaceuticals Inc. stock deliver surprise earnings beatTrade Volume Report & Free Verified High Yield Trade Plans - Улправда
Breakout Move: Can NovaBay Pharmaceuticals Inc stock sustain institutional interestSwing Trade & Stock Timing and Entry Methods - Bộ Nội Vụ
Novabay Pharmaceuticals stock hits 52-week high at 11.49 USD - Investing.com
Highs Report: Will NovaBay Pharmaceuticals Inc. stock outperform value stocksShort Setup & Safe Entry Point Alerts - Улправда
How geopolitical tensions affect NovaBay Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Verified Momentum Watchlists - Улправда
Can NovaBay Pharmaceuticals Inc. (B9P0) stock ride next bull market cycleJuly 2025 Momentum & AI Forecasted Stock Moves - ulpravda.ru
Can NovaBay Pharmaceuticals Inc. stock sustain institutional interestWeekly Trading Summary & Fast Moving Stock Watchlists - ulpravda.ru
How NovaBay Pharmaceuticals Inc. (B9P0) stock reacts to weak economyWeekly Stock Recap & Daily Momentum Trading Reports - ulpravda.ru
How NovaBay Pharmaceuticals Inc. stock reacts to bond yields2025 Market Overview & Risk Controlled Swing Alerts - ulpravda.ru
Will NovaBay Pharmaceuticals Inc. (B9P0) stock issue positive guidanceJuly 2025 Rallies & Step-by-Step Trade Execution Guides - Улправда
Novabay Pharmaceuticals Inc Stock (NBY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.27%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):